Skip to Content

IM Cannabis Corp IMCC

Morningstar Rating
$2.25 −0.09 (3.85%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IMCC is trading at a 618% premium.
Price
$2.25
Fair Value
$6.80
Uncertainty
Extreme
1-Star Price
$52.38
5-Star Price
$2.40
Economic Moat
Mntd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IMCC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.34
Day Range
$2.162.35
52-Week Range
$1.278.10
Bid/Ask
$2.23 / $2.45
Market Cap
$5.02 Mil
Volume/Avg
13,326 / 188,093

Key Statistics

Price/Earnings (Normalized)
0.14
Price/Sales
0.07
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
95

Valuation

Metric
IMCC
Price/Earnings (Normalized)
0.14
Price/Book Value
Price/Sales
0.07
Price/Cash Flow
Price/Earnings
IMCC

Financial Strength

Metric
IMCC
Quick Ratio
0.37
Current Ratio
0.65
Interest Coverage
Quick Ratio
IMCC

Profitability

Metric
IMCC
Return on Assets (Normalized)
−49.78%
Return on Equity (Normalized)
−483.79%
Return on Invested Capital (Normalized)
−87.12%
Return on Assets
IMCC
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
XrsmtbmqqDjr$81.5 Bil
Merck KGaA ADR
MKKGY
YhfhyvxlnMsxwfnv$70.9 Bil
Haleon PLC ADR
HLN
FdklsbvpCdl$40.1 Bil
Viatris Inc
VTRS
VvgtrlncRtv$14.1 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
HkrgsvzDsytc$13.2 Bil
Catalent Inc
CTLT
FmzrfzfcBhmhq$10.5 Bil
Perrigo Co PLC
PRGO
XjbmbzwJgym$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
YlvxksrLyfylx$3.5 Bil
Curaleaf Holdings Inc
CURLF
HvqdmvlcrPrm$3.1 Bil
Green Thumb Industries Inc
GTBIF
PnqhctqyqHcst$2.6 Bil

Sponsor Center